Tag Archives: One Madison Avenue

Business, Finance, Occupation & Industry

Caesarstone Announces Pricing of Ordinary Shares Offering by Selling Shareholders

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Caesarstone Announces Pricing of Ordinary Shares Offering by Selling Shareholders

MP MENASHE, Israel–(BUSINESS WIRE)– Caesarstone Sdot-Yam Ltd. (NAS: CSTE) , a leading manufacturer of high quality engineered quartz surfaces, today announced the pricing at $23.25 per share of an underwritten public offering of 7,775,000 ordinary shares offered by its shareholders, Kibbutz Sdot-Yam and Tene Investment Fund. The selling shareholders have also granted the underwriters a 30-day option to purchase up to 1,166,250 additional ordinary shares. Caesarstone will not receive any proceeds from the offering. The offering is expected to close on April 17, 2013.

J.P. Morgan Securities LLC, Barclays Capital Inc. and Credit Suisse Securities (USA) LLC acted as joint bookrunning managers for the offering, and Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co. Incorporated acted as co-managers for the offering.

A shelf registration statement (including a prospectus) relating to these securities was filed by Caesarstone and declared effective on April 5, 2013 by the Securities and Exchange Commission (SEC). A copy of the prospectus supplement and base prospectus relating to the offering may be obtained by contacting: J.P. Morgan Securities LLC, via telephone at (866) 803-9204 or by mail at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; Barclays Capital Inc., via telephone at (888) 603-5847, by mail at c/o Barclays Capital Inc. at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or barclaysprospectus@broadridge.com; or Credit Suisse Securities (USA) LLC, via telephone at (800) 221-1037, by mail at Prospectus Department, One Madison Avenue, New York, NY, 10010 or newyork.prospectus@credit-suisse.com. Before you invest, you should read these documents and other documents filed by Caesarstone with the SEC for more complete information. You may obtain these documents free of charge by visiting the SEC‘s website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Caesarstone

Caesarstone manufactures high quality engineered quartz surfaces, which are used in both residential and commercial buildings as countertops and other interior surfaces. The wide variety of colors, styles, designs and textures of Caesarstone® products, along

From: http://www.dailyfinance.com/2013/04/11/caesarstone-announces-pricing-of-ordinary-shares-o/

Business, Finance, Occupation & Industry

Caesarstone Announces Offering of Ordinary Shares by Selling Shareholders

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Caesarstone Announces Offering of Ordinary Shares by Selling Shareholders

MP MENASHE, Israel–(BUSINESS WIRE)– Caesarstone Sdot-Yam Ltd. (NAS: CSTE) , a leading manufacturer of high quality engineered quartz surfaces, today announced that its shareholders, Kibbutz Sdot-Yam and Tene Investment Fund, are offering for sale 7,250,000 ordinary shares of the company in an underwritten public offering. Caesarstone will not receive any proceeds from the offering.

J.P. Morgan Securities LLC, Barclays Capital Inc. and Credit Suisse Securities (USA) LLC are the joint bookrunning managers for the proposed offering, and Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co. Incorporated are the co-managers for the proposed offering.

A shelf registration statement (including a prospectus) relating to these securities was filed by Caesarstone and declared effective on April 5, 2013 by the Securities and Exchange Commission (SEC). A copy of the prospectus supplement and base prospectus relating to the offering may be obtained by contacting: J.P. Morgan Securities LLC, via telephone at (866) 803-9204 or by mail at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; Barclays Capital Inc., via telephone at (888) 603-5847, by mail at c/o Barclays Capital Inc. at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or barclaysprospectus@broadridge.com; or Credit Suisse Securities (USA) LLC, via telephone at (800) 221-1037, by mail at Prospectus Department, One Madison Avenue, New York, NY, 10010 or newyork.prospectus@credit-suisse.com. Before you invest, you should read these documents and other documents filed by Caesarstone with the SEC for more complete information. You may obtain these documents free of charge by visiting the SEC‘s website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Caesarstone

Caesarstone manufactures high quality engineered quartz surfaces, which are used in both residential and commercial buildings as countertops and other interior surfaces. The wide variety of colors, styles, designs and textures of Caesarstone® products, along with Caesarstone’s inherent characteristics such as hardness, non-porous, scratch and stain resistance and durability, provide consumers with a product competitive to granite, manufactured solid surfaces and laminate, as well as to other engineered quartz surfaces. Caesarstone’s four collections …read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Colony Financial, Inc. Announces Pricing of Convertible Senior Notes

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Colony Financial, Inc. Announces Pricing of Convertible Senior Notes

LOS ANGELES–(BUSINESS WIRE)– Colony Financial, Inc. (the “Company”) (NYS: CLNY) today announced the pricing of its public offering of $175,000,000 aggregate principal amount of its 5.00% Convertible Senior Notes due 2023 (the “Notes”) for total gross proceeds of $175 million. The Company has granted to the underwriters a 30-day option to purchase up to an additional $25,000,000 aggregate principal amount of the Notes to cover over-allotments, if any. The Notes will bear interest at a rate equal to 5.00% per year, payable semiannually in arrears on April 15 and October 15 of each year, beginning on October 15, 2013. The conversion rate will initially equal 42.3819 shares of common stock per $1,000 principal amount of Notes, which is equivalent to a conversion price of approximately $23.60 per share of common stock, representing a 10% conversion premium based on the closing price of the Company’s common stock of $21.45 per share on April 4, 2013. The initial conversion rate is subject to adjustment upon the occurrence of certain events, but will not be adjusted for any accrued and unpaid interest. The Notes will mature on April 15, 2023. The offering is expected to close on or about April 10, 2013, subject to customary closing conditions.

The Company intends to use the net proceeds from the offering to acquire its target assets in a manner consistent with its investment strategies and investment guidelines and for working capital and general corporate purposes.

Goldman, Sachs & Co., BofA Merrill Lynch, Credit Suisse and J.P. Morgan are acting as the joint book-running managers for this offering.

The offering of the Notes will be made under the Company’s automatically effective shelf registration statement, which was filed with the Securities and Exchange Commission. The offering will be made only by means of a prospectus supplement and prospectus, which have been filed with the Securities and Exchange Commission. Before you invest, you should read the applicable prospectus supplement and prospectus for more complete information about the Company and the offering. You may obtain these documents free of charge by visiting the SEC website at www.sec.gov. Alternatively, you may obtain copies by contacting Goldman, Sachs & Co., at 200 West Street, New York, NY 10282,Attention: Prospectus Department, by telephone at 1-866-471-2526 or by emailing prospectus-ny@ny.email.gs.com, BofA Merrill Lynch, at 222 Broadway, New York, NY 10038, Attention: Prospectus Department or by emailing dg.prospectus_requests@baml.com, Credit Suisse Securities (USA) LLC at One Madison Avenue, New York, New York 10010, Attention: Prospectus Department, by telephone (toll …read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Colony Financial, Inc. Announces Public Offering of Convertible Senior Notes

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Colony Financial, Inc. Announces Public Offering of Convertible Senior Notes

LOS ANGELES–(BUSINESS WIRE)– Colony Financial, Inc. (the “Company”) (NYS: CLNY) today announced its plans to commence a public offering of $150,000,000 aggregate principal amount of Convertible Senior Notes due 2023 (the “Notes”). The Company also plans to grant to the underwriters a 30-day option to purchase up to an additional $22,500,000 aggregate principal amount of the Notes to cover over-allotments, if any. The interest rate, conversion rate and other terms of the Notes will be determined at the time of pricing of the offering.

The Company intends to use the net proceeds from the offering to acquire its target assets in a manner consistent with its investment strategies and investment guidelines and for working capital and general corporate purposes.

Goldman, Sachs & Co., BofA Merrill Lynch, Credit Suisse and J.P. Morgan will act as the joint book-running managers for this offering.

The offering of the Notes will be made under the Company’s automatically effective shelf registration statement, which was filed with the Securities and Exchange Commission. The offering will be made only by means of a prospectus supplement and prospectus, which will be filed with the Securities and Exchange Commission. Before you invest, you should read the applicable prospectus supplement and prospectus for more complete information about the Company and the offering. You may obtain these documents free of charge by visiting the SEC website at www.sec.gov. Alternatively, you may obtain copies, when available, by contacting Goldman, Sachs & Co., at 200 West Street, New York, NY 10282, Attention: Prospectus Department, by telephone at 1-866-471-2526 or by emailing prospectus-ny@ny.email.gs.com, BofA Merrill Lynch, at 222 Broadway, New York, NY 10038, Attention: Prospectus Department or by emailing dg.prospectus_requests@baml.com, Credit Suisse Securities (USA) LLC at One Madison Avenue, New York, New York 10010, Attention: Prospectus Department, by telephone (toll free) at (800) 221-1037 or by e-mailing newyork.prospectus@credit-suisse.com, or J.P. Morgan Securities LLC c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by telephone at (866) 803-9204.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Colony Financial, Inc.
…read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Enanta Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of Underwriters' Ov

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Enanta Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option

WATERTOWN, Mass.–(BUSINESS WIRE)– Enanta Pharmaceuticals, Inc. (NAS: ENTA) , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced the closing of its initial public offering of 4,600,000 shares of its common stock at a price to the public of $14.00 per share, which includes the exercise in full by the underwriters of their over-allotment option to purchase up to 600,000 additional shares of common stock. Enanta Pharmaceuticals common stock is listed on the NASDAQ Global Select Market under the trading symbol “ENTA”. All of the shares in the offering were offered by Enanta Pharmaceuticals.

J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC acted as joint book-running managers for the offering. Leerink Swann LLC and JMP Securities LLC acted as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on March 20, 2013. This offering was made solely by means of a prospectus. A copy of the final prospectus relating to the offer may be obtained by contacting J.P. Morgan Securities LLC via Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by calling toll-free (866) 803-9204; or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, or by calling toll-free (800) 221-1037, or by emailing newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction

About Enanta

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. Enanta is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes – protease (partnered with AbbVie), NS5A (partnered with Novartis) and nucleotide polymerase – as well as a host-targeted antiviral (HTA) inhibitor class targeted against cyclophilin. Additionally, Enanta has created a new class of antibiotics, called Bicyclolides, for the treatment of multi-drug resistant bacteria, with …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Enanta Pharmaceuticals Announces Pricing of Initial Public Offering

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Enanta Pharmaceuticals Announces Pricing of Initial Public Offering

WATERTOWN, Mass.–(BUSINESS WIRE)– Enanta Pharmaceuticals, Inc. (NAS: ENTA) , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $14.00 per share. The shares of Enanta’s common stock will trade on the NASDAQ Global Select Market under the symbol “ENTA” beginning on March 21, 2013. All of the shares of common stock are being offered by Enanta. In addition, Enanta has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock to cover over-allotments, if any. The offering is expected to close on March 26, 2013, subject to customary closing conditions.

J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC are acting as joint book-running managers for the offering. Leerink Swann LLC and JMP Securities LLC are acting as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on March 20, 2013.

The offering will be made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from J.P. Morgan Securities LLC via Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by calling toll-free (866) 803-9204; or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, or by calling toll-free (800) 221-1037, or by emailing newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Enanta

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. Enanta is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes – protease (partnered with AbbVie), NS5A (partnered with Novartis) and nucleotide polymerase – as well as a host-targeted antiviral (HTA) …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Chesapeake Energy Corporation Announces Pricing of $2.3 Billion Senior Notes Offering

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Chesapeake Energy Corporation Announces Pricing of $2.3 Billion Senior Notes Offering

OKLAHOMA CITY–(BUSINESS WIRE)– Chesapeake Energy Corporation (NYS: CHK) today announced that it has priced its previously announced public offering of $2.3 billion in aggregate principal amount of its senior notes at par. As previously announced, the offering will include three series of notes: $500 million in 3.25% Senior Notes due 2016; $700 million in 5.375% Senior Notes due 2021; and $1.1 billion in 5.75% Senior Notes due 2023. Chesapeake expects the issuance and delivery of all three series of senior notes to occur on April 1, 2013, subject to customary closing conditions.

Chesapeake intends to use a portion of the net proceeds from the offering to purchase the portion of its 7.625% Senior Notes due 2013 and 6.875% Senior Notes due 2018 that are tendered in its concurrent tender offers for such notes. Chesapeake plans to use a substantial portion of the remaining net proceeds to redeem its 6.775% Senior Notes due 2019 at par value (subject to receipt of a favorable ruling in a declaratory judgment action currently pending with respect to Chesapeake’s ability to redeem such notes at par value). To the extent that any portion of the net proceeds of the offering is not used as described above, Chesapeake plans to use such net proceeds to purchase, repay and/or redeem any of its 7.625% Senior Notes due 2013 not tendered in the concurrent tender offer and to purchase, repay and/or redeem over time other outstanding indebtedness, including indebtedness outstanding under its corporate revolving bank credit facility.

The senior notes were offered pursuant to an effective shelf registration statement filed August 3, 2010 with the U.S. Securities and Exchange Commission. Chesapeake intends to list the notes on the New York Stock Exchange after issuance. Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC, Citigroup Global Markets Inc., Goldman Sachs & Co. and Wells Fargo Securities, LLC acted as joint book-running managers for the offering. Copies of the prospectus relating to the offering may be obtained from Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor New York, NY 10014, by telephone at (866) 718-1649 or by email at prospectus@morganstanley.com or Credit Suisse at Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010, by telephone at (800) 221-1037 or by email at newyork.prospectus@credit-suisse.com. An electronic copy of the preliminary prospectus supplement is available on the website of the Securities and Exchange Commission at www.sec.gov.

This press release shall not …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Silver Spring Networks Announces the Closing of its Initial Public Offering and Full Exercise of the

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Silver Spring Networks Announces the Closing of its Initial Public Offering and Full Exercise of the Underwriters’ Over-Allotment Option

REDWOOD CITY, Calif.–(BUSINESS WIRE)– Silver Spring Networks, Inc. (NYS: SSNI) , a leading networking platform and solutions provider for smart energy networks, today announced the closing of its previously announced initial public offering of 5,462,500 shares of common stock at a price to the public of $17.00 per share, which included 712,500 shares of common stock issued upon the exercise in full of the underwriters’ option to purchase additional shares to cover over-allotments. All of the shares sold in the offering were sold by Silver Spring Networks. The shares began trading on The New York Stock Exchange on March 13, 2013 under the symbol “SSNI.”

Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC acted as joint book-running managers for the offering and Stifel, Nicolaus & Company, Incorporated, Piper Jaffray & Co., Canaccord Genuity Inc., Evercore Group L.L.C., Pacific Crest Securities LLC and Robert W. Baird & Co. acted as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on March 12, 2013. This offering was made solely by means of a prospectus. A copy of the final prospectus related to the offering may be obtained from: Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526 or by emailing prospectus-ny@ny.email.gs.com or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, New York 10010, telephone: 1-800-221-1037 or by emailing newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Investor Contact
Silver Spring Networks, Inc.
Tricia Gugler,650-839-4504
Investor Relations
tgugler@silverspringnet.com
or
Media Contact
Global Communications
Noel Hartzell, 650-839-4184nhartzell@silverspringnet.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article Silver Spring Networks Announces the Closing of its Initial Public Offering and Full Exercise of the Underwriters’ Over-Allotment Option originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Chesapeake Energy Corporation Announces $2.3 Billion Senior Notes Offering

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Chesapeake Energy Corporation Announces $2.3 Billion Senior Notes Offering

OKLAHOMA CITY–(BUSINESS WIRE)– Chesapeake Energy Corporation (NYS: CHK) today announced that it is commencing a public offering of $2.3 billion in aggregate principal amount of its senior notes, which the company expects will be issued in three separate series, one maturing in 2016, another maturing in 2021 and the last maturing in 2023.

Chesapeake intends to use a portion of the net proceeds from the offering to purchase the portion of its 7.625% Senior Notes due 2013 and 6.875% Senior Notes due 2018 that are tendered in its concurrent tender offers for such notes. Chesapeake plans to use a substantial portion of the remaining net proceeds to redeem its 6.775% Senior Notes due 2019 at par value (subject to receipt of a favorable ruling in a declaratory judgment action currently pending with respect to Chesapeake’s ability to redeem such notes at par value). To the extent that any portion of the net proceeds of the offering is not used as described above, Chesapeake plans to use such net proceeds to purchase, repay and/or redeem any of its 7.625% Senior Notes due 2013 not tendered in the concurrent tender offer and to purchase, repay and/or redeem over time other outstanding indebtedness, including indebtedness outstanding under its corporate revolving bank credit facility.

The senior notes are being offered pursuant to a shelf registration statement filed August 3, 2010, with the U.S. Securities and Exchange Commission. Chesapeake intends to list the notes on the New York Stock Exchange after issuance. Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC, Citigroup Global Markets Inc., Goldman, Sachs & Co. and Wells Fargo Securities, LLC will act as joint book-running managers for the notes offering. Copies of the prospectus relating to the offering may be obtained from Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor New York, NY 10014, by telephone at (866) 718-1649 or by email at prospectus@morganstanley.com or Credit Suisse at Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010, by telephone at (800) 221-1037 or by email at newyork.prospectus@credit-suisse.com. An electronic copy of the preliminary prospectus supplement will be available on the website of the Securities and Exchange Commission at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Silver Spring Networks Prices Initial Public Offering

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Silver Spring Networks Prices Initial Public Offering

REDWOOD CITY, Calif.–(BUSINESS WIRE)– Silver Spring Networks, Inc. (NYS: SSNI) , a leading networking platform and solutions provider for smart energy networks, today announced the pricing of its initial public offering of 4,750,000 shares of common stock at a price to the public of $17.00 per share. The shares are expected to begin trading on The New York Stock Exchange on March 13, 2013 under the symbol “SSNI.” All of the shares being sold in the offering are being sold by Silver Spring Networks. The underwriters have a 30-day option to purchase up to an additional 712,500 shares of common stock from Silver Spring Networks at the initial public offering price.

Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC are acting as joint book-running managers for the offering and Piper Jaffray & Co., Stifel, Nicolaus & Company, Incorporated, Robert W. Baird & Co., Canaccord Genuity Inc., Evercore Group L.L.C., and Pacific Crest Securities LLC are acting as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on March 12, 2013. This offering is being made solely by means of a prospectus, copies of which may be obtained from: Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526 or by emailing prospectus-ny@ny.email.gs.com or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, New York 10010, telephone: 1-800-221-1037 or by emailing newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Investor Contact
Silver Spring Networks
Tricia Gugler, 650-839-4504
Investor Relations
tgugler@silverspringnet.com
or
Media Contact
Silver Spring Networks
Noel Hartzell, 650-839-4184
Global Communications
nhartzell@silverspringnet.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article Silver Spring Networks Prices Initial Public Offering originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range …read more
Source: FULL ARTICLE at DailyFinance